platinum has been researched along with Coronary Restenosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dauler, M; Haldis, TA; Maehara, A; Mehran, R; Myers, P; Peng, Y; Popma Almonacid, A; Price, MJ; Shlofmitz, RA; Spriggs, DJ | 1 |
| Aizawa, Y; Fujita, S; Fuse, K; Hatada, K; Ikeda, Y; Kishi, S; Matsubara, T; Okabe, M; Sato, T; Takahashi, M | 1 |
| De la Torre Hernandez, JM; Garcia Camarero, T; Gorria, GM; Lee, DH; Lerena, P; Sainz Laso, F; Zueco, J | 1 |
| Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Ko, YG; Shin, DH | 1 |
| Allocco, DJ; Calabria, P; Capodanno, D; Crowley, JJ; Dawkins, KD; Erglis, A; Gilbert, TJ; Horváth, IG; Menown, IB; Moreno, R; Tamburino, C | 1 |
| Allocco, DJ; Carrié, D; Erglis, A; Hamm, CW; Masotti, M; Mego, D; Underwood, P; Wang, JC; Watkins, MW | 1 |
| Allocco, DJ; Dawkins, KD; Fang, Q; Gao, R; Han, Y; Hou, Y; Li, H; Wang, H; Xu, B; Yang, Y; Yu, B; Zhang, J | 1 |
| Allocco, DJ; Ball, M; Bertolet, B; Cannon, LA; Dauber, I; Dawkins, KD; Foster, M; Kereiakes, DJ; Nersesov, AY; Underwood, PL | 1 |
| Ando, K; Domei, T; Enomoto, S; Hiromasa, T; Hyodo, M; Iwabuchi, M; Kuramitsu, S; Mazaki, T; Shinozaki, T; Shirai, S; Soga, Y; Yamaji, K | 1 |
| Butera, G; Carminati, M; Marini, D | 1 |
| Calais, F; Carlsson, J; Götberg, M; James, S; Lagerqvist, B; Nilsson, J; Nilsson, T; Olivecrona, G; Sarno, G; Sjögren, I | 1 |
| Böse, D; Churzidze, S; Doerfler, A; Erbel, R; Naber, CK; Schmermund, A | 1 |
6 trial(s) available for platinum and Coronary Restenosis
| Article | Year |
|---|---|
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.
Topics: Aged; Angina, Stable; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Iridium; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States | 2018 |
A real all-comers randomized trial comparing Xience Prime and Promus Element stents.
Topics: Aged; Angina, Stable; Angina, Unstable; Chromium Alloys; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Everolimus; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Sirolimus; Thrombosis; Treatment Outcome | 2013 |
Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
Topics: Aged; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Republic of Korea; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2015 |
Primary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Patient Safety; Platinum; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Single-Blind Method; Stents; Survival Rate; Time Factors; Treatment Outcome | 2015 |
PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions.
Topics: Adult; Aged; Cardiovascular Agents; China; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Single-Blind Method; Time Factors; Treatment Outcome | 2015 |
Long-term follow-up of the platinum chromium TAXUS Element (ION) stent: The PERSEUS Workhorse and Small Vessel trial five-year results.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Bayes Theorem; Chromium; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Patient Selection; Platinum; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Taxus; Time Factors; Treatment Outcome; United States | 2015 |
6 other study(ies) available for platinum and Coronary Restenosis
| Article | Year |
|---|---|
Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and cobalt c
Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Renal Dialysis; Risk Factors; Trace Elements; Treatment Outcome | 2018 |
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Topics: Aged; Cardiovascular Diseases; Chromium; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Reoperation; Treatment Failure; Treatment Outcome; Tubulin Modulators | 2015 |
Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Risk Factors; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2015 |
In-stent restenosis and aneurysm development after bare stent implantation: rescue by e-PTFE-covered cheatham- platinum stent.
Topics: Adolescent; Adult; Angioplasty; Aortic Coarctation; Coronary Aneurysm; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platinum; Polytetrafluoroethylene; Stents; Treatment Outcome | 2010 |
Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Platinum; Registries; Sirolimus; Sweden; Treatment Outcome | 2013 |
[Percutaneous coil embolization of a large, congenital coronary-pulmonary fistula using hydrophilic-coated detachable platinum coils].
Topics: Angioplasty, Balloon, Coronary; Arterio-Arterial Fistula; Blood Flow Velocity; Coated Materials, Biocompatible; Combined Modality Therapy; Coronary Restenosis; Coronary Vessel Anomalies; Embolization, Therapeutic; Humans; Male; Middle Aged; Platinum; Prostheses and Implants; Pulmonary Artery; Radiography; Retreatment; Stents | 2004 |